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Abstract: The biocompatibility of chemoenzymatically
generated dextran-acrylate hydrogels has been evaluated in
vitro, using human foreskin fibroblasts, and in vivo, by sub-
cutaneous and intramuscular implantation in Wistar rats for
up to 40 days. In vitro tests show that hydrogel extracts only
minimally reduced (10%) the mitochondrial metabolic ac-
tivity of fibroblasts. Direct contact of the hydrogels with cells
induced a cellular proliferation inhibition index (CPII) of
50–80%, compared with a control, whereas through indirect
contact, the CPII values were16%, suggesting that the high
CPII values achieved in the direct assay test were likely due
to mechanical stress or limitations in oxygen diffusion.
Hence, the hydrogels were noncytotoxic. Moreover, cell–
material interaction studies show that these hydrogels were
nonadhesive. Finally, histologic evaluation of tissue re-
sponse to subcutaneous and intramuscular implants showed
acceptable levels of biocompatibility, as characterized by a
normal cellular response and the absence of necrosis of the
surrounding tissues of the implant. In the first 10 days, the
foreign-body reaction in the intramuscular implantation was
more severe than in subcutaneous implantation, becoming
identical after 30 days. In both cases, dextran hydrogels did
not show signs of degradation 6 weeks postimplantation
and were surrounded by a thin fibrous capsule and some
macrophages and giant cells. This response is typical with a
number of nondegradable biocompatible materials. These
results indicate that dextran hydrogels are biocompatible,
and may have suitable applications as implantable long-
term peptide/protein delivery systems or scaffolds for tis-
sue engineering. © 2004 Wiley Periodicals, Inc. J Biomed
Mater Res 68A: 584–596, 2004
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INTRODUCTION
Recently, we described a novel chemoenzymatic
strategy for the preparation of dextran acrylates.1 The
biocatalytic approach was highly regioselective in the
sites of acrylic ester modification of the dextran back-
bone and resulted in controlled degree of acrylate
substitution. Hydrogels were obtained upon free rad-
ical polymerization of aqueous solutions of dextran-
acrylate. These hydrogels may have suitable applica-
tions as implantable protein delivery systems,2,3
because of the highly stabilizing effect of polysaccha-
rides on proteins and other biological macromole-
cules,4,5 as protein- and cell-resistant coatings,6–8 and
as bioactive scaffolds for tissue engineering.9,10 In this
last case, the cell adhesive properties of the scaffold
can be promoted by the immobilization of cell adhe-
sion peptides targeted to specific cell types.11,12 In-
deed, dextran has multiple binding sites along its
chain which can incorporate high concentrations of
bioactive molecules.8
Irrespective of their specific use and destination,
biocompatibility is a prerequisite that makes dextran
hydrogels implantable. Nevertheless, few studies
have been performed in vitro13 and in vivo14 on bio-
compatibility of dextran-based hydrogels. The present
study was undertaken to assess the biocompatibility
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of dextran-acrylate hydrogels that were synthesized
chemoenzymatically. In vitro biocompatibility tests
were performed using human foreskin fibroblasts,
which are known to have a major role in cutaneous
wound healing.15,16 Hydrogel biocompatibility was
evaluated according to the extract assay, direct or
indirect contact assays, and cell adhesion.13,17,18 In vivo
biocompatibility and degradability were determined
after subcutaneous and intramuscular implantation
into Wistar rats for up to 40 days. These results indi-
cate that dextran hydrogels are biocompatible and the
inflammatory and healing responses of rat tissues
were influenced by the initial water content and the
degree of substitution (DS) of the hydrogels.
EXPERIMENTAL PROTOCOL
Materials
Dextran (from Leuconostoc mesenteroides, dexT70, Mn 
39,940, Mw  70,000, according to the manufacturer’s spec-
ification) was obtained from Fluka Chemie AG (Buchs, Swit-
zerland). Dimethylsulfoxide, N,N,N,N-tetramethylenedia-
mine (TEMED), and ammonium persulfate (APS) were
purchased from Aldrich (Milwauke, WI). Dextran acrylates
(dexT70-VA) with different DS were synthesized as de-
scribed previously.1 The products were characterized by 1H
NMR to assess DS. Dulbecco’s modified Eagle medium
(DMEM) with glutamax-I (Gibco, UK) was supplemented
with 10% fetal bovine serum (Gibco), 1% of fungizone (250
g/mL amphotericin B; Gibco) and 0.5% gentamicin (10
mg/mL; Gibco). This medium is further referred to as
DMEM complete medium. MTT (3-[4,5-dimethylthiazol-2-
yl]-2,5-diphenyl-tetrazolium bromide) was obtained from
Sigma (St. Louis, MO). Transwell plates (six wells) were
purchased from Corning (Corning, NY) and were formed by
a suspended tissue culture-treated polycarbonate membrane
(24-mm diameter; 8.0-m pore size) and a polystyrene plate.
All other chemicals and solvents used in this work were of
the highest purity commercially available.
Gel preparation
Dext70-VA hydrogels were obtained by free radical poly-
merization of aqueous solutions of dexT70-VA as a function
of DS and monomer concentration. Dext70-VA (80 or 200
mg) was dissolved in 0.9 mL of 0.2 M phosphate buffer, pH
8.0, and bubbled with nitrogen for 2 min. The polymeriza-
tion reactions, performed in a cell culture plate (diameter
1.8 cm), were initiated by adding 50 L of APS (80 mg/mL
in 0.2 M phosphate buffer, pH 8.0) and 50 L of TEMED
solution [13.6% (v/v) in water; pH adjusted to 8.0 with 12 N
HCl], and allowed to proceed for 24 h at 25°C. The hydrogels
synthesized contained an initial water content of 92% (w/w)
and 80% (w/w), when 80 mg and 200 mg of dexT70-VA
macromonomer were used, respectively, and maintaining
constant the other components.
Swelling ratio determination
After removal of the hydrogels from the plate, they were
immersed in about 50 mL of 0.01M citrate-phosphate buffer,
pH 7.0, changing the buffer daily, at 25°C (in some cases,
after removing the hydrogels, they were dried and weighed
to determine their initial dry weight). At regular intervals,
the swollen gels were removed, blotted with filter paper to
remove surface water, weighed, and returned to the same
container until weight stabilization (Ws) was observed (nor-
mally up to 7 days). In some cases, the hydrogel disks were
steam-sterilized for 20 min at 120°C followed by equilibra-
tion of the hydrogels for 24 h at 25°C. The hydrogels were
then dried at room temperature, under vacuum, in the pres-
ence of phosphorous pentoxide (until constant weight was
achieved), and weighed to determine the dry weight, Wd.
The swelling ratio at equilibrium (SRE) was calculated ac-
cording to Equation (1):
SRE 
WsWd
Wd
(1)
The gel fraction of hydrogels was calculated from the ratio
of the dry weight of hydrogel after swelling and the initial
dry weight immediately after the polymerization reaction.
The sol fraction was calculated as 1  gel fraction.
In vitro biocompatibility tests
Cell culture
Primary human skin fibroblasts were grown in DMEM
complete medium, at 37°C, in a fully humidified air contain-
ing 5% CO2 (IR auto Flow). The cells were fed every 2–3
days. When cells reached confluence, the culture medium
was discarded and the cells were washed with 5 mL of 10
mM phosphate-buffered saline (PBS) pH 7.4 (Gibco). The
cells were then detached with 2 mL of 0.05% (w/v) trypsin
[1:250, from porcine pancreas (Sigma)] solution [PBS supple-
mented with 0.1 and 0.25% of -D() glucose and ethyl-
enediaminetetracetic acid, respectively] for 5 min at 37°C, and
3 mL of DMEM complete medium was added to inactivate the
trypsin after cell detachment. The cells were centrifuged (10
min, 2500 rpm) and resuspended in culture medium before
use. Cultures between the third and seventh passages were
used in the entire work (ca. 20 can be used without loss of
fibroblast-like phenotype and cell proliferation rate).
Solutions of dextran, dexT70-VA, TEMED, and APS
All solutions were prepared on the day of application.
Solutions of 10, 20, 50, and 100 mg of dextran or dexT70-VA
(DS 7.2% or DS 12.1%) per milliliter of DMEM complete and
solutions of 2.5, 10, 30, and 50 L of APS or TEMED per
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milliliter of DMEM complete medium were sterilized
through a 0.22-m filter (Schleicher & Schuell, Dassel, Ger-
many), with the exception of 100 mg/mL dexT70-VA solu-
tions for which a 0.45-m filter (Schleicher & Schuell) was
used because of the higher viscosity.
Extraction assay
The extraction assay was performed with two sets of
hydrogels. In one set, the hydrogels obtained after polymer-
ization of dextran-acrylate were extracted for 2 days in 10
mM citrate-phosphate buffer pH 7.0 (3 	 40 mL), at 25°C,
and afterward autoclaved. In the second set, the hydrogels
obtained after the polymerization reaction were immersed
in 10 mL of 10 mM citrate-phosphate pH 7.0 and immedi-
ately autoclaved. Extracts were obtained by immersing au-
toclaved hydrogels in DMEM (without phenol red) culture
medium supplemented with 1% fungizone and 0.5% genta-
micin, at 37°C, for 5 days with agitation (120 rpm). The ratio
between the surface area of the material and the volume of
extraction medium was 3 cm2/mL. After incubation, the
medium containing the extract was collected, filtered (0.22
m; to eliminate the possible presence of solid particles of
the material), and supplemented with 10% serum. Human
skin fibroblasts were plated in 96-well plates (TPP, Switzer-
land) and grown to subconfluency. The culture medium was
removed and replaced with the extract media for 24 h at
37°C. Phenol (64 g/L, BDH), which is considered cyto-
toxic,17 was used as a positive control. Culture medium
without extracts, incubated as described above, was used as
a negative control. After incubation, the extracts were dis-
carded and the mitochondrial metabolic activity of the cells
was measured with the MTT assay. To test the cytotoxicity
of dextran, dexT70-VA, TEMED, and APS solutions (see
above), 100 L of each test solution was added to each well
plated with subconfluent cells.
CPII assay: Direct contact assay
The CPII assay was performed according to De Groot et
al.,13 which allows cytotoxicity evaluation on growing cells.
To evaluate the CPII for solutions of dextran, dexT70-VA,
TEMED, and APS, 100 L of a fibroblast suspension con-
taining 1.55 	 104 cells/mL was plated into each well of a
96-well plate. Because each well has a surface area of 0.31
cm2, the final seeding density was about 5 	 103 cells/cm2.
After 4 h (the cells were adherent to the well bottom), the
culture medium was discarded and 200 L of each test
solution was added to each well. For the control culture, the
medium was refreshed. Seventy-two hours after the addi-
tion of test solutions, the extracts were discarded and the cell
layer was washed with PBS to remove remaining materials
and loose cells. The metabolic activity of the cells was then
measured with the MTT test (see below). The CPII was
calculated using Equation (2):
CPII  100  OD540 of test cultureOD540 of control culture 100 (2)
To evaluate the CPII for dexT70-VA hydrogels (extracted
for 3 days in water at 25°C and then sterilized by autoclave),
3 mL of a fibroblast suspension containing 1.5 	 104
cells/mL was plated into each well of a six-well plate, to
yield a final density of 5 	 103 cells/cm2. After 4 h, the
culture medium was refreshed (3 mL) and the hydrogels
were added to the wells, in direct contact with cells [Fig.
1(A)]. For the control culture, the culture medium was re-
freshed. After 72 h of incubation, the metabolic activity of
the cells was assessed as previously described above and the
CPII calculated according to Equation (2).
CPII assay: Indirect contact assay
The CPII of hydrogel samples was also evaluated using
transwell plates, containing a final density of 5 	 103 cells/
cm2 [Fig. 1(B)]. In this case, after polymerization (without
any extraction), the hydrogels were sterilized by autoclav-
ing, washed twice with DMEM complete medium, and
seeded into the wells in indirect contact with the cells (total
of 4 mL of culture medium). After 72 h of incubation, the
metabolic activity of the cells was determined as described
above for the direct contact assay, and the CPII calculated
according to Equation (2).
Figure 1. Schematic representation of the direct (A) and indirect (transwell experiment) (B) contact assays. Both assays use
growing cells instead of subconfluent cells as in the extraction assay.
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Cell adhesion assay
Filtered (0.45 m) dexT70-VA solutions (450 L) were
placed into each well of a 24-well plate and polymerized by
addition of filtered APS (25 L) and TEMED (25 L) solu-
tions, in sterile conditions. After 24 h of polymerization, the
hydrogels covering the bottom of the wells were washed
with DMEM complete medium (3 	 450 L) and 1.0 	 104
cells/cm2 were seeded onto the surface. After 24 h of incu-
bation, the hydrogels were washed with PBS (2 	 450 mL)
and the cells trypsinized and counted using a cell counting
chamber (Nfubauer, Germany).
Mitochondrial metabolic activity assay
For 96-well plates, the cell layers were rinsed with PBS
(110 L) and 110 L of MTT (0.45 mg/mL in DMEM com-
plete medium without phenol red) was added to each well.
For six-well plates, after PBS washing (1 mL), 2.5 mL of MTT
solution was added. After 3 h of incubation at 37°C, the MTT
solution was removed and the insoluble formazan crystals
formed in the bottom of the wells were dissolved in 100 L
or 1 mL of dimethylsulfoxide, for 96- and 6-well plates,
respectively. The absorbance was measured at 540 nm using
a plate reader (STL Spectra III, Austria).
In vivo biocompatibility studies
Animals
Male Wistar rats (8–10 weeks old) were obtained from the
Faculty of Medicine of Coimbra University and used for all
studies. Rats were given standard feed and water ad libitum
and were on a 12-h light/dark cycle. European community
guidelines (no. 86/609/CE; corresponding to decree no.
1005/92 of Portuguese legislation) for the care and use of
laboratory animals were observed.
Implantation studies
Aseptic techniques were used for all surgical procedures.
Animals were anesthetized with Ketalarz (50 mg kg1;
Parke-Davis) and an area of the back and front was shaved
and washed with Betadine. In the front, two incisions along
the spine (ca. 1 cm in length) were made and two subcuta-
neous pockets were created. The gels (3 	 2 mm, 3-mm
thickness) were placed into the pocket away from the inci-
sion (ca. 0.5 cm) and the skin was closed with Mersilk
nonabsorbable suture (3 s; Ethicon). In the back, two inci-
sions along the spine (ca. 1 cm in length) were made and a
further incision was performed in each case in the skeletal
muscle (Gluteus superficialis) to implant the gel. The muscle
incision was closed with sterile polypropylene suture (6 s;
Ethicon) and the skin incision closed with Mersilk suture
(see above). The two areas were washed with Betadine
dermic solution and the rats kept warm with a heating pad
for 1 h after the surgical procedure and finally transferred to
a cage. Three rats were used for each time point. As controls,
subcutaneous and intramuscular pockets were made with-
out implants.
Histological examination
The rats were euthanized and the implants with sur-
rounding tissue were carefully dissected and fixed in 4%
(v/v) neutral buffered formalin, for at least 3 days. The
blocks were sliced perpendicular or cross-sectional to the
implanted hydrogels. The implant and adjacent tissue were
oriented and placed in processing cassettes, taken through a
graded ethanol series (Shandon Citadel 1000) and embebbed
in paraffin. The samples were then sectioned using a mic-
rotome (Shandon Retraction AS 325), and finally deparaf-
finized and stained either with hematoxylin/eosin, periodic
acid-schiff (PAS), or Masson’s trichrome.19 Multiple photo-
graphs were taken of each hydrogel and the surrounding
tissues using a Nikon microscope (Eclipse E 600) with a
Nikon camera (FOX-35). The tissue response was rated by
two persons. Capsule thickness was measured on nine fields
per section, obtained from different blocks.
Statistical analysis
One-way analysis of variance with Bonferroni post test
was performed for statistical tests by using GraphPad Prism
3.0 (San Diego, CA) software package. A p value of  0.01
was considered to be statistically significant.
RESULTS
Several DexT70-VA hydrogels were prepared che-
moenzymatically as described previously.1 SRE and
gel fraction were dependent on both the initial water
content of the gel and the DS, as well as further
treatment by autoclaving. As shown in Table I, the gel
fractions of nonsterilized dexT70-VA hydrogels were
between 59 and 83%, which indicates that incubation
of these networks in water at 37°C leads to consider-
able release of polymeric components. Subsequent au-
toclaving did not alter significantly the gel fraction,
thus showing that this step did not hydrolyze the
hydrogel network. SRE values ranged from 3.7 to 31
for nonsterilized hydrogels (Table I). In addition, the
treatment by autoclaving slightly increased the SRE,
particularly in hydrogels with low initial water con-
tent (80%).
In vitro biocompatibility
Cytotoxicity assays
To identify whether components of the hydrogel
synthesis procedure were cytotoxic, subconfluent hu-
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man skin fibroblasts were exposed to extracts of hy-
drogels prepared with different DS values and initial
water contents. Cellular viability was quantified using
the standard MTT assay.20 Two sets of hydrogels were
used for the extraction assay. In one set, the hydrogels
were extracted in 10 mM citrate-phosphate buffer, pH
7.0, for 2 days and then autoclaved. In the second set,
the hydrogels obtained after polymerization were im-
mediately autoclaved. Afterward, both sets of hydro-
gels were extracted in cell culture medium for 5 days
at 37°C and the extracts incubated with fibroblast cul-
tures for 24 h. The results of the MTT assays [Fig. 2(A)]
show that the extracts of all hydrogels induce 20%
change in the mitochondrial metabolic activity of fi-
broblasts (MMAF), as compared with the control.
Nonextracted hydrogels with an initial water content
of 92% exerted a statistically significant increase in
MMAF (10–20%); however, no effect was observed in
extracted hydrogels. In some cases, extracted or non-
extracted hydrogels with an initial water content of
80% induced an approximately 10% reduction in
MMAF.
Dextran hydrogels can release leachable products
during the extraction assay (Table I) and, therefore,
the cytotoxicity of individual hydrogel components
was evaluated. Solutions of dextran, dexT70-VA
monomers with different DS values (7.2 and 12.1%;
dexT70-VA DS 31.5% was not evaluated because of
restrictions in the amount), APS, and TEMED were
incubated with fibroblast cultures for 24 h under the
same conditions as described for dexT70-VA hydro-
gel extracts, and the cellular viability assessed by
the MTT assay [Fig. 2(B)]. Dextran solution at a
concentration of 10 mg/mL induced a statistically
significant (p  0.001) increase in the MMAF (ca.
20%), although this effect was not significant in the
concentration range of 20–100 mg/mL. In contrast,
dexT70-VA monomers with different DS values
slightly reduced (10–20%) the MMAF at 50 mg/mL;
however, did so extensively (
80%) at concentra-
tions of 100 mg/mL. Finally, TEMED and APS ex-
erted a significant (p  0.001) decrease in MMAF for
concentrations 
2.5 L/mL.
Cytotoxicity studies were extended to evaluate the
CPII. To that end, the toxicity of either hydrogels or
single components of the hydrogels was evaluated in
actively growing cell culture for 72 h. As shown in
Figure 3(A), the CPII values of dextran solutions in the
TABLE I
Characteristics of dexT70-VA Hydrogels
DexT70-VA
Hydrogel
Gel Fractiona
(%) SREd
BSb ASc BSb ASc
92%, DS 7.2% 59.0 55.7 31.5 36.6
92%, DS 12.1% 74.5 74.3 14.4 14.4
92%, DS 22.4% — — 11.0 11.5
92%, DS 31.5% — 77.8 9.78 10.6
80%, DS 7.2% 80.2 78.5 7.32 10.2
80%, DS 12.1% 83.0 84.7 4.39 5.86
80%, DS 22.4% — — 3.99 5.32
80%, DS 31.5% — 81.1 3.72 4.80
aThe hydrogels were extracted in water for 5 days (in
some cases further sterilized by autoclave), dried, and
weighed. The final dry weights were compared with the
sample initial dry weight (immediately after the polymer-
ization reaction) to calculate the gel fraction. Average of two
independent measurements.
bBefore sterilization by autoclave.
cAfter sterilization by autoclave.
dSwelling ratio at equilibrium. Average of two indepen-
dent measurements.
Figure 2. (A) The mitochondrial metabolic activity
(mean  SD, n  6) of human skin fibroblasts cultured for
24 h with extracts from 92% (white bars) and 80% (black
bars) dexT70-VA hydrogels with different DS values, as
determined by the MTT assay (reported as percentage of the
negative controls). Hydrogels denoted as extraction indi-
cates that the hydrogels were immersed in citrate-phosphate
buffer, 10 mM pH 7.0, for 2 days before autoclaving. w/o,
without. (B) The mitochondrial metabolic activity (mean 
SD, n  6) of human skin fibroblasts cultured with dextran,
dexT70-VA with different DS values, TEMED, and APS, for
24 h, as determined by the MTT assay (reported as percent-
age of the negative controls). *p  0.01 and **p  0.001 in
comparison with negative controls.
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concentration range of 10–20 mg/mL were about 18%,
not statistically different from the control; however, at
higher concentrations, the CPII significantly (p 
0.001) increased to about 35%. CPII values of
dexT70-VA monomers with DS 7.2 and 12.1% were
between 36 and 64% for a concentration range of
10–20 mg/mL, and this was increased to about 80% at
higher concentrations. Finally, APS caused a signifi-
cant reduction in the MMAF for all concentrations
(CPII values of ca. 90%), albeit with TEMED the same
phenomenon was observed above 2.5 L/mL.
The cytotoxicity of dexT70-VA hydrogels was also
assessed by the CPII test using a direct contact method
[Fig. 3(B)]. Specifically, the hydrogels were seeded into
the cellular layer of a six-well plate [Fig. 1(A)].
DexT70-VA hydrogels with low DS (7.2%) yielded
higher values of CPII (70–80%) than high DS hydro-
gels (ca. 52%). Because the hydrogels have different
diameters after swelling, the CPII was normalized per
diameter of the hydrogel. In this case, the CPII values
were identical which indicates that hydrogel size had
an important role.
Light microscopy was also undertaken to charac-
terize the morphology of the cells under and in the
proximity of the hydrogels [Fig. 3(C–F)]. Cells in the
proximity of the hydrogels appeared to have normal
morphology, as compared with the control [Fig.
3(C)], and were well spread on the polystyrene ma-
trix (data not shown). However, for dextran hydro-
gels with low DS (7.2%), independent of the water
content, the cells underneath the hydrogels were
less elongated and less well spread [Fig. 3(D,E)]. In
contrast, the cells under the 80% dexT70-VA DS
12.1% hydrogel [Fig. 3(F)] did not present a signif-
icantly different morphology, as compared with the
control cells albeit they were lower in number.
To assess whether the high values of CPII obtained
by the direct contact assay were truly due to hydrogel
toxicity or to other side effects, an indirect contact
assay [transwell experiment, Fig. 1(B)] was performed.
As shown in Figure 4, the CPII decreased to values
16% and were not statistically different from the
control.
Cell-adhesion assay
Cell adhesion onto hydrogels was evaluated and
expressed as a percentage of control adhesion on tis-
sue culture polystyrene (TCPS) [Fig. 5(A)]. Fibroblast
adhesion was reduced in all hydrogels tested with
different DS values and initial water contents (28%).
Because dextran hydrogels were transparent, cell mor-
phology was evaluated by phase-contrast inverted
light microscopy [Fig. 5(B,C)]. After 24 h of cell incu-
bation in the presence of the hydrogels, the relatively
few cells attached were rounded and formed clusters
Figure 3. (A) The cell (human skin fibroblasts) prolifera-
tion inhibition index (CPII) (mean SD, n 6) after 72 h for
dextran, dexT70-VA with different DS values, TEMED, and
APS solutions, as determined by the MTT assay. (B) The
CPII (white bars, mean  SD, n  2) or CPII normalized by
diameter of hydrogel (black bars) after 72 h, for dexT70-VA
hydrogels with different DS values in direct contact with
cells, as determined by the MTT assay. (C–F) Micrographs
from phase-contrast inverted light microscopy of human
skin fibroblasts cultured for 72 h, underneath dexT70-VA
hydrogels (D–F) or in the absence of hydrogel (C). In (D),
92% DS 7.2%; (E), 80% DS 7.2%; and (F), 80% DS 12.1%.
Original magnification, 200	. *p  0.01 and **p  0.001 in
comparison with negative controls.
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without filopodia to anchor the cells to the hydrogels,
as observed by scanning electron microscopy (data not
shown).
In vivo biocompatibility
DexT70-VA hydrogel samples were subcutaneous
and intramuscularly implanted in rats and the inten-
sity of the inflammatory response to the foreign im-
plants was monitored by histology at varying implan-
tation times. Table II provides an overview of the
nature and extent of the observed tissue reaction after
implantation of hydrogels with different initial water
contents and DS values.
Subcutaneous implantation
At day 2, 80% dexT70-VA DS 7.2% was mainly
surrounded by fibroblasts. Some lymphocytes, but
no granulocytes, were observed [Fig. 6(A,B)]. Fibrin
and exudate were also identified in the proximity of
the hydrogel. In contrast, the other dextran hydro-
gels did show the presence of granulocytes to dif-
ferent extents, which were attached to the interface
of the hydrogel/tissue. Typically, dextran hydrogels
with high initial water content attracted higher
numbers of granulocytes, and also yielded greater
vascularization.
At day 5 after implantation, the cell layer surround-
ing the 80% dexT70-VA hydrogel DS 7.2% consisted
primarily of fibroblasts but also of smaller fractions of
granulocytes and lymphocytes. The other dextran hy-
drogels did not present granulocytes. In 80%
dexT70-VA DS 22.4% hydrogel, some foreign-body
giant cells (FBGC) were already observed.
At day 10, the start of fibrous capsule was observed
in the 80% dexT70-VA DS 7.2% hydrogel, and macro-
phages and fibroblasts were found between this cap-
sule and the hydrogel [Fig. 6(C,D)]. No granulocytes,
exudate, and fibrin were found at this stage. Lympho-
cytes were observed only occasionally and the number
of blood vessels remained approximately constant as
compared with the previous postimplantation time.
Similar tissue reactions were observed for the other
dextran hydrogels. For 92% dexT70-VA DS 7.2% hy-
drogel, the fragmentation was higher than that ob-
served for the other hydrogels (in general restricted to
the outer limits), likely because of mechanical stress on
this relatively soft hydrogel. Finally, giant cells were
observed for hydrogels with lower initial water con-
tents (80%), whereas they were absent in hydrogels
with higher initial water contents (92% dexT70-VA DS
7.2%).
At day 30, 80% dexT70-VA DS 7.2% hydrogel was
surrounded by a thin layer of macrophages and fibro-
blasts and a fibrous capsule had formed around this
layer (thickness of ca. 54.50  23.28 m, n  2) [Fig.
6(E,F)]. The same profile was observed in the other
hydrogels, and the interface of the hydrogel/tissue
was less vascularized than at day 10. Finally, in the
Figure 5. (A) Human skin fibroblasts adhesion (mean 
SD, n  3) into dexT70-VA hydrogels with different DS
values and initial water contents. TCPS was used as control.
(B,C) Micrographs from phase-contrast inverted light mi-
croscopy of fibroblast adhesion after culturing for 24 h on
TCPS (B) and 80% dexT70-VA DS 12.1% hydrogel (C). Orig-
inal magnification, 200	.
Figure 4. The cell (human skin fibroblasts) proliferation
inhibition index (CPII) (mean  SD, n  3) after 72 h for
dexT70-VA hydrogels with different DS values in indirect
contact with cells (transwell experiment, see text for further
details), as determined by an MTT assay.
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Figure 6. Representative light micrographs of 80% dexT70-VA DS 7.2% hydrogel implanted subcutaneously and surround-
ing tissue (perpendicular slice) at different time points, stained with hematoxylin/eosin (A,B,G,H) and Masson’s trichrome
(C–F). Top side is skin; bottom side is underlying muscle (M). (A,B) At day 2, a moderate inflammatory reaction (IR) is seen
surrounding the hydrogel (H): a fibrin layer (f) containing lymphocytes (closed arrow) and fibroblasts (open arrow) is in
contact with the hydrogel, whereas some exudate (e) is underlying it. (C,D) At day 10, macrophages and fibroblasts (MF) were
surrounding the hydrogel (H) and these were evolved by a starting fibrous capsule (fc). (E,F) At day 30, a moderate
foreign-body reaction is seen surrounding the hydrogel (H): a layer of macrophages and fibroblasts (MF) is seen in the
proximity of hydrogel which is surrounded by a fibrous capsule (fc; thickness of ca. 54 m). (G,H) At day 40, a minimal
foreign-body reaction is surrounding the hydrogel (H) which is identified by a thin fibrous capsule (ca. 35 m) with some
macrophages (closed arrow) and fibroblasts (open arrow). Some blood vessels (V) are also present in the surrounding tissue.
(A,C,E,G) original magnification, 5	; (B,F,H) 100	; (D) 50	.
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92% dexT70-VA DS 7.2%, the fragments were sur-
rounded by a thin discontinuous capsule, whereas on
80% dexT70-VA DS 22.4% hydrogel, giant cells were
found.
At day 40, 80% dexT70-VA DS 7.2% hydrogel [Fig.
6(G,H)] was covered by one or two layers of macro-
phages and fibroblasts including some giant cells. This
cell layer was surrounded by a thin fibrous capsule
(35.14  21.58 m, n  4). Similar tissue reactions
were observed for the other dextran hydrogels, except
for 92% dexT70-VA DS 7.2% hydrogel where the net-
work was highly fragmented and no continuous fi-
brous capsule was observed. The fragments were sur-
rounded mainly by fibroblasts and no giant cells were
observed. Furthermore, the cells appeared to begin to
invade the hydrogel.
Intramuscular implantation
After intramuscular implantation of hydrogels (Ta-
ble II), the observed tissue reactions were more severe
than those described for subcutaneous implantation.
At an early stage (day 2), an intense inflammatory
process was observed at the implantation site with
80% dexT70-VA DS 7.2%. Granulocytes and mono-
nucleated cells infiltrated into muscle tissue, and mus-
cle cell necrosis (as measured by the presence of
“ghost cells”, i.e., weakly stained cells) was observed.
Similar tissue reactions were found for the remaining
hydrogels; however, hydrogels with lower water con-
tents (80%) showed slightly higher initial tissue re-
sponse than dextran hydrogels with higher water con-
tents (92%), as indicated by the increased infiltration
of granulocytes (Table II) into the implantation area.
To check whether this response was due to the im-
plant or to the extent or degree of defect created by the
implantation procedure, histologic evaluation on rats
with unfilled surgical implant was performed. Tissue
responses with the same intensity and extent were
observed, indicating that the procedure of implanta-
tion had a more significant effect on tissue response
than the biomaterial itself.
The aforementioned tissue reaction had decreased
by day 10, and granulocytes originally at the implan-
tation site were replaced by mononucleated cells with
the start of fibrous capsule observed. At days 30 and
40, the cellular infiltration of muscle cells was delim-
ited to small areas and the necrosis process ceased. A
thin fibrous capsule (40 m) was observed at days 30
and 40 for all hydrogels tested with the exception of
92% dexT70-VA DS 7.2% hydrogel, where a continu-
ous fibrous capsule was not observed even after 40
days. At these implantation times, the hydrogels were
surrounded by fibroblasts, macrophages, and some
giant cells. Higher numbers of giant cells were ob-
served in dextran hydrogels with lower initial water
contents (80%).
In general, the fragmentation process was large in
92% dexT70-VA DS 7.2% hydrogel, reaching in some
cases about 80% of the overall area. This process was
minimal with the other hydrogels, normally occurring
only at the outer limits of the gel networks. As ex-
pected, the hydrogel fragmentation was higher for
intramuscular than subcutaneous implantation, pre-
sumably because of the mechanical stress promoted
by the movement of the animal.
To assess the degradability of hydrogels, the tissue
surrounding hydrogels was stained with PAS.14,19 All
tissue sections (subcutaneous or intramuscular im-
plants) were PAS staining negative, which indicated
that cells did not uptake (e.g., by phagocytosis) the
hydrogels, during the time frame of this study.
DISCUSSION
The information obtained from sol–gel fractions is
important for biocompatibility assessment, as either
unreacted monomers or polymerization initiators may
be cytotoxic. Our results show that hydrogels pre-
pared with lower initial water contents in the poly-
merization reaction had higher gel fractions, and con-
sequently lower sol fractions (i.e., unreacted
monomers that can be released from the hydrogel).
This is not surprising because the reaction of highly
concentrated solutions of dextran acrylate monomers
is favored over low concentrated ones.1
The likely leachable products from dexT70-VA hy-
drogels showed different in vitro biocompatibility pro-
files. Dextran had a minimal effect on cell viability.
The only effect was observed at low concentrations (10
mg/mL) and consisted of a slight increase in MMAF.
This effect can be attributed to the increase of either
cell viability or the mitochondrial succinic dehydroge-
nase enzyme activity (responsible for MTT metabo-
lism) or possibly both by an unknown mechanism.
Regarding cell proliferation, dextran exhibited a rela-
tive inhibition of 18–35% depending on its concentra-
tion. Similar CPII values (25  7%) were reported
previously13 for dextran with a molecular weight of 40
kDa (100 mg/mL) using human skin fibroblasts and
using similar conditions as used in the current study.
Considering that the sol fraction of hydrogels was
less than 22 and 44% (Table I) for 80 and 92%
dexT70-VA hydrogels, respectively, the maximum
amount of dexT70-VA released will be 43 mg/mL.
In this concentration range, dexT70-VA monomer
with different DS values slightly decreased (10–20%)
cell viability; however, it exerted a pronounced effect
on cell proliferation, which was significantly different
from that exhibited by dextran itself. This effect may
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be related to the presence of vinyl groups that may
interfere with cell proliferation. Finally, as expected,
either APS or TEMED reduced substantially cell via-
bility and dramatically cell proliferation. This effect
was expected, because free radicals can react with
biological molecules (lipids, proteins, carbohydrates,
and nucleic acids) and thus interfere with cell viability
and proliferation.21
Dextran hydrogels showed good in vitro biocompat-
ibility. Using the extraction assay, dextran hydrogels
did not reduce cell viability by more than about 10%
(suggesting that APS and TEMED were not released
during extraction), and this effect was only observed
with hydrogels prepared with an initial water content
of 80%. Interestingly, nonextracted hydrogels with an
initial water content of 92% induced a significant in-
crease in the MMAF. This may be due to the release of
small amounts of dextran (or dexT70-VA that is de-
graded in solution into dextran by hydrolysis of the
acrylate ester linkages) from these hydrogels, which
increases the MMAF as already demonstrated in hy-
drogel component cytotoxicity tests. Unexpectedly,
the CPII assay (direct contact) results showed that
these polymeric networks exerted pronounced cell
proliferation inhibition (53–80%) when compared
with the control, and this effect was dependent on the
size of hydrogels. Hydrogels with larger diameters
presented higher CPII; however, the differences
among hydrogels were found to be negligible upon
normalizing the CPII as a function of the hydrogel
diameter. In addition, differences in cell morphology
and number were observed for cells underneath the
hydrogels but not in their proximity. This effect may
be related to mechanical stress of the hydrogels on the
cells or poor O2/CO2 exchange due to the physical
presence of the network. Indeed, the CPII values ob-
tained by the indirect contact assay were 16% and
not significantly different from the control. Hence,
dextran hydrogels only slightly reduced cell viability
(10%) and cell proliferation (16%) and, therefore,
may be considered as noncytotoxic polymer networks.
The study of dextran hydrogel interaction with fi-
broblasts showed that the hydrogels were nonadhe-
sive compared with TCPS. This resistance to cell ad-
hesion was presumably due to poor protein
adsorption6,7 onto the hydrophilic and nonionic dex-
tran. Similar results were obtained by Massia and
Stark8 in surfaces grafted with dextran, using endo-
thelial and smooth muscle cells, and 3T3 fibroblasts.
Moreover, these authors reported cell adhesion values
26% for all types of cells, which agrees well with our
results. The cell adhesion resistance of dextran hydro-
gels should not be interpreted as a sign of nonbiocom-
patibility, because other polymers such as polyethyl-
ene glycol have similar properties yet are widely
recognized as biocompatible.11
Finally, we demonstrated that dextran hydrogels
are biocompatible in vivo, as determined through sub-
cutaneous and intramuscular implantation studies in
rats. The inflammatory and healing responses of rat
tissues were influenced either by the implantation
process (subcutaneous versus intramuscular) or the
DS values and initial water content of the hydrogels.
After subcutaneous implantation of dexT70-VA hy-
drogels, the hydrogels with higher water contents
(92%) showed slightly higher inflammatory response,
as expressed by a higher number of attached neutro-
phils, when compared with hydrogels with lower wa-
ter contents (80%). It is well known that the primary
role of neutrophils is phagocytosis, and these cells are
attracted to the implantation site by several factors,
including chemoattraction due to the coating of the
foreign body with opsonins.22 We speculate that the
higher number of neutrophils in the proximity of hy-
drogels with higher water contents may be attributed
to the more open structure of these hydrogels1 as
compared with lower water content hydrogels, and
this would likely promote the entrapment of opsonins.
Furthermore, the release of leachable products, due to
a higher fragmentation process in these hydrogels
(mainly in 92% dexT70-VA DS 7.2% hydrogel), may
attract a high number of granulocytes.
After 10 days, a normal wound-healing response to
subcutaneously implanted hydrogels occurred, which
varied according to the properties of the hydrogel.
Hydrogels with higher DS values presented a higher
number of FBGC than those with lower DS values.
FBGC are formed by fusion from macrophages23 and
that process is dependent on the form, composition,
and topography of the implanted surface.15,24 In gen-
eral, rough surfaces induce higher FBGC formation
than smooth and flat surfaces.24,25 According to light
microscopy observations, the surface of dextran hy-
drogels with higher DS values was rougher than those
with lower DS values, and this may explain the higher
number of FBGC observed in those hydrogels. Fur-
thermore, the wound-healing response was also char-
acterized by the formation of a fibrous capsule involv-
ing the hydrogel, except for 92% dexT70-VA DS 7.2%
hydrogel. In this case, a higher degree of hydrogel
fragmentation affected the formation of a continuous
fibrous capsule, and the surrounding cells began to
invade the hydrogel. In the other hydrogels, the end-
stage fibrous capsule formation is a typical response of
biocompatible polymers that do not undergo biodeg-
radation or bioresorption.15,16 The thickness of the
fibrous capsule at day 40 (55 m for all hydrogels) is
comparable to26 or slightly lower27,28 than other bio-
compatible materials described in the literature when
implanted subcutaneously into rats during about 6
weeks. Indeed, this parameter is important in evalu-
ating the performance of implantable drug delivery
systems and scaffolds, as thick fibrous capsule may
impede the diffusion of therapeutic substances and
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prevent effective implant integration. Along those
lines, it has been demonstrated that fibrous capsule
thickness of 10–35 m does not circumvent the release
of insulin from poly(hydroxyethyl methacrylate)
sponges implanted in rats.29 Therefore, it is likely that
the capsule thickness values obtained herein would
not interfere in therapeutic protein release from hy-
drogels. Further studies are now underway to dem-
onstrate protein release from implanted dextran-based
hydrogels.
The tissue response by intramuscular implantation
of hydrogels was more severe than the subcutaneous
implantation. The degeneration process during the
first 5–10 days was likely ascribed to surgical trauma30
caused by the intramuscular implantation, and this
was confirmed by similar tissue reaction in the un-
filled surgical implant site control. Therefore, the
higher degree of surgical trauma during the first 10
days precludes our ability to clearly interpret the bio-
logical response to the hydrogels. However, at days 30
and 40, the tissue response showed the formation of a
thin fibrous capsule (40 m) for all hydrogels ex-
cluding 92% dexT70-VA DS 7.2% hydrogel, as well as
minor and well-confined infiltration of fibroblasts and
macrophages at the muscle tissue, likely due to the
movement of the hydrogel relatively to the tissue.
Thus, dextran hydrogels present acceptable muscle
tissue compatibility. Finally, after about 6 weeks of
either subcutaneous or intramuscular implantation,
the hydrogels did not show signs of degradation.
Hence, the acrylate ester linkages are stable at physi-
ologic pH and the presence of esterolytic enzymes in
tissues. This agrees with previous studies showing the
nondegradability of dextran-methacrylate hydrogels14
obtained by chemical routes.
In summary, in vitro biocompatibility studies have
demonstrated that chemoenzymatically generated
dextran-based hydrogels do not significantly promote
cell adhesion and minimally impact cell viability and
proliferation. These hydrogels, therefore, may be con-
sidered noncytotoxic. In vivo studies indicated that all
hydrogels elicited a mild inflammatory response after
subcutaneous implantation; however, intramuscular
implantation resulted in trauma, which partially
masked a potential inflammatory response from hy-
drogel implantation. Nevertheless, the foreign-body
reaction was normal for subcutaneous and intramus-
cular implantation and varied according to the DS
value and initial water content of hydrogels. Thus,
dextran hydrogels can be considered as biocompatible
networks, because the cellular response after implan-
tation was normal, the fibrous capsule surrounding
hydrogels had a thickness similar to those of other
biocompatible materials, and neither damage nor ne-
crosis of the surrounding tissues of the implant was
observed.
The authors thank Miguel Trigo Carvalho for skilled tech-
nical assistance.
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